Long Focus Capital Management, LLC - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 45 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Long Focus Capital Management, LLC ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q3 2023$87,200
-16.2%
40,0000.0%0.00%
-40.0%
Q2 2023$104,000
+116.7%
40,0000.0%0.01%
+66.7%
Q1 2023$48,000
-26.4%
40,0000.0%0.00%
-25.0%
Q4 2022$65,200
+33.1%
40,0000.0%0.00%
-20.0%
Q3 2022$49,000
+22.5%
40,0000.0%0.01%
+25.0%
Q2 2022$40,000
-36.5%
40,0000.0%0.00%
-50.0%
Q1 2022$63,000
+12.5%
40,0000.0%0.01%
+14.3%
Q4 2021$56,00040,0000.01%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 173,511$241,0000.04%
Advisor Resource Council 100,000$139,0000.01%
BRAVE ASSET MANAGEMENT INC 20,000$28,0000.01%
Aquatic Capital Management LLC 2,600$4,0000.01%
Long Focus Capital Management, LLC 40,000$56,0000.01%
Newman Dignan & Sheerar, Inc. 13,915$19,0000.01%
Disciplined Investments, LLC 5,189$7,0000.00%
Cedar Mountain Advisors, LLC 5,651$8,0000.00%
TWO SIGMA SECURITIES, LLC 27,125$38,0000.00%
SITTNER & NELSON, LLC 1,000$1,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders